Gabrilovich Lab

Our lab studies the role of the #TumorMicroenvironment in the regulation of #ImmuneResponses in #Cancer with a specific emphasis on #MyeloidCells 🔬

[Kevin Alicea-Torres @KAlicea_PhD]

Really nice to have met my former thesis advisor, Dr. Dmitry Gabrilovich with who I never had the chance to say goodbye after my defense in 2020 due to COVID-19. Two years after, we finally had our long overdue dinner celebration! Truly appreciate his mentorship & guidance. 🙏🏼

[Nature Communications @NatureComms]

IFNAR1-mediated type I IFN signaling restricts the acquisition of immune-suppressive activity by myeloid derived suppressor cells.
https://t.co/npqaRhnRvW
#CancerResearch @KAlicea_PhD

[Journal of Experimental Medicine @JExpMed]

Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice. A new study from @FilippoVeglia81, ⁦@AyumiMofongo, @GabrilovichLab and colleagues. https://t.co/9VGXCArc6e
#Innateimmunity #Tumorimmunology

[Journal of Experimental Medicine @JExpMed]

Veglia et al. @GabrilovichLab characterize the heterogeneity of polymorphonuclear neutrophils (PMNs) in cancer. The identification of neutrophil populations with potent immune suppressive activity opens selective targeting opportunities. https://t.co/9VGXCArc6e
#Tumorimmunology

[Ayumi Hashimoto, Ph.D.🇯🇵 @Ayumi_PhD]

Our recent study is published on Journal of Experimental Medicine.

[Dr. Arnaldo Díaz @ADiaz_PhD]

Congrats to @AliceaK15, #PennSUIP/#PennPREP alumnus & @CAMBUpenn PhD candidate in the @GabrilovichLab @TheWistar, on been named @AAASMassMedia fellow. The passion & commitment you put on your projects is admirable. @ElNuevoDia has won an excellent professional & role model.

[The Wistar Institute @TheWistar]

Congratulations to @TheWistar’s Drs. Gabrilovich & Dang for making the top 1% of the world’s most cited researchers in their fields! @webofscience #HighlyCited2019 @Ludwig_Cancer https://t.co/mvdD3cFj5B

[The Wistar Institute @TheWistar]

Check out @TheWistar predoctoral fellow @AliceaK15’s interview with @Telemundo62 reporter Alberto Rullán during Progress & Promise Against Cancer @AACR @NBCphiladelphia https://t.co/65vxKxpN5u

[The Wistar Institute @TheWistar]

Congratulations to @TheWistar’s Dr. Dmitry I. Gabrilovich on receiving the most prestigious research grant from the @AmericanCancer to further his groundbreaking research in tumor immunology. https://t.co/2pv0QumsgG

[Ayumi Hashimoto, Ph.D.🇯🇵 @Ayumi_PhD]

Celebrating Dmitry’s award “ACS professorship” with this tumor micro environment cake. #scientificbaker #neutrophilcookies #TMEcake #immunology

[Filippo Veglia @FilippoVeglia81]

My mentor Dmitry Gabrilovich has been appointed as Research professor by the American Cancer society for his contribution in advancing the understanding of the biology of myeloid cells in cancer.
https://t.co/xqYrqoKUMv
@TheWistar @GabrilovichLab @cancer @AmericanCancer

[Kevin Alicea-Torres @KAlicea_PhD]

My PI got a prestigious grant 🥳Congrats to Dmitry Gabrilovich, MD/PhD, for receiving the #Research Professorship Award from the @AmericanCancer! Proud to be part of the @GabrilovichLab🔬#AttackingCancer at the @TheWistar👨🏻‍🔬@ACSNews @Penn_IFI @IGGPenn @PennMedBench

[Filippo Veglia @FilippoVeglia81]

Thrilled to share our latest work on FATP2 as a new regulator of suppressive functions of neutrophils in cancer. @nature @gabrilovichlab @TheWistarInstitute
Fatty acid transport protein 2 reprograms neutrophils in cancer https://t.co/rifaJnzov4

[Ayumi Hashimoto, Ph.D.🇯🇵 @Ayumi_PhD]

American Cancer Society Awards New Research and Training Grants https://t.co/YiwQAsaSzt

[Dr. Arnaldo Díaz @ADiaz_PhD]

Jade Matthews-Balcombe, a biology major @BklynCollege411, is part of the #PennSUIP @Penn, & this summer she is working in the @GabrilovichLab @TheWistar under the mentorship of @aliceak15 developing a new immunotherapy-based approach to target immune suppressor cells in cancer